Modeling cancer processes with CRISPR-Cas9

被引：9

作者：

Lu, Xiao-Jie ^{[1
]}

Qi, Xiaolong ^{[2
,3
]}

Zheng, Dong-Hui ^{[4
]}

Ji, Li-Juan ^{[5
]}

机构：

[1] Tongji Univ, Shanghai East Hosp, Sch Med, Dept Gastroenterol, Shanghai 200092, Peoples R China

[2] Zhengzhou Univ, Affiliated Hosp 1, Ctr Canc, Biotherapy Ctr, Zhengzhou 450052, Peoples R China

[3] Tongji Univ, Tongji Hosp, Sch Med, Dept Gastroenterol & Hepatol, Shanghai 200092, Peoples R China

[4] Second Peoples Hosp Huaian, Dept Nephrol, Huaian, Peoples R China

[5] Second Peoples Hosp Huaian, Dept Rehabil, Huaian, Peoples R China

来源：

TRENDS IN BIOTECHNOLOGY | 2015年 / 33卷 / 06期

关键词：

GENOME; GENERATION; NUCLEASES; EVENTS;

D O I：

10.1016/j.tibtech.2015.03.007

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

CRISPR-Cas9 is an RNA-guided site-specific DNA editing tool which, together with its reprogrammed versions such as nickase Cas9 and dead Cas9, enables quick modeling of desired combinations of cancer-associated genomic and/or epigenetic aberrations simultaneously or sequentially, thus facilitating massive functional interrogations and therapy testing.

引用

页码：317 / 319

页数：3

共 50 条

[41] Principles of DNA cleavage in CRISPR-Cas9
Ahsan, Mohammad
Nierzwicki, Qukasz
East, Kyle W.
Binz, Jonas
Hsu, Rohaine V.
Arantes, Pablo R.
Skeens, Erin
Pacesa, Martin
Jinek, Martin
Lisi, George P.
Palermo, Giulia
BIOPHYSICAL JOURNAL, 2023, 122 (03) : 170A - 170A
[42] CRISPR-Cas9 System: Opportunities and Concerns
Vasiliou, Stella K.
Diamandis, Eleftherios P.
Church, George M.
Greely, Henry T.
Baylis, Francoise
Thompson, Charis
Schmitt-Ulms, Gerold
CLINICAL CHEMISTRY, 2016, 62 (10) : 1304 - 1311
[43] Secondary Conformational Checkpoint in CRISPR-Cas9
Zhao, Shuxin
Liu, Jin
Zuo, Zhicheng
JOURNAL OF CHEMICAL THEORY AND COMPUTATION, 2024, 20 (09) : 3440 - 3448
[44] Who owns CRISPR-Cas9 in Europe?
András Kupecz
Nature Biotechnology, 2014, 32 : 1194 - 1196
[45] Chemistry Nobel Honors CRISPR-Cas9
You Li-Lan
Sun Wei
Yang Xiao-Qi
Wang Yan-Li
PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2020, 47 (11) : 1119 - 1126
[46] Expanded Alternatives of CRISPR-Cas9 Applications in Immunotherapy of Colorectal Cancer
Arroyo-Olarte, Ruben
Mejia-Munoz, Aranza
Leon-Cabrera, Sonia
MOLECULAR DIAGNOSIS & THERAPY, 2024, 28 (01) : 69 - 86
[47] The synchronized catalytic dance of CRISPR-Cas9
Saha, Aakash
Pindi, Chinmai
Palermo, Giulia
NATURE CATALYSIS, 2023, 6 (10) : 870 - 872
[48] Controlling CRISPR-Cas9 Gene Editing
Dowdy, Steven F.
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (03): : 289 - 290
[49] Multidimensional chemical control of CRISPR-Cas9
Maji, Basudeb
Moore, Christopher L.
Zetsche, Bernd
Volz, Sara E.
Zhang, Feng
Shoulders, Matthew D.
Choudhary, Amit
NATURE CHEMICAL BIOLOGY, 2017, 13 (01) : 9 - 11
[50] CRISPR-Cas9 genome editing for cancer immunotherapy: opportunities and challenges
Chen, Ming
Xu, Jiang
Zhou, Yang
Zhang, Silin
Zhu, Di
BRIEFINGS IN FUNCTIONAL GENOMICS, 2020, 19 (03) : 183 - 190

← 1 2 3 4 5 →